06/04/2026
🦷 The Future of Teeth: Could Drugs Replace Dental Implants?
In a scientific first, researchers in Japan are testing an experimental drug that might one day enable the human body to regrow natural teeth, potentially reducing or replacing the need for dental implants and dentures. ďż˝
Futura +1
đź’ˇ What Is Being Studied?
The drug is called TRG‑035 — a monoclonal antibody therapy being developed by biotech company Toregem BioPharma in collaboration with Kyoto University researchers. �
Teeth Regrowth Clinic
TRG‑035 targets a protein known as USAG‑1 (also called SOSTDC1), which normally acts as a molecular “off” switch that stops new teeth from forming after childhood. By blocking USAG‑1, the drug reactivates dormant tooth‑forming cells that most humans still carry in their jaws. �
Teeth Regrowth Clinic
🔬 How the Science Works
Human biology: Humans naturally grow two sets of teeth — baby teeth and adult teeth. After that, the genetic program that makes teeth becomes inactive. �
Teeth Regrowth Clinic
Dormant tooth buds: Research shows that tiny remnants of “third” tooth buds remain in the jaw even after the adult set forms. They just stay silent because of the USAG‑1 protein. �
Teeth Regrowth Clinic
Blocking USAG‑1: TRG‑035 is designed to block this protein, allowing natural tooth‑formation signals (like BMP pathways) to restart. In animals, this has led to full new teeth with roots and enamel. �
Dental News
đź§« Animal Success Before Human Trials
Before human studies, the antibody was tested in mice and ferrets. These animal trials showed that a single dose could produce fully functional new teeth in the jaws of treated animals, without major safety problems. ďż˝
Dental News
🧑‍⚕️ What’s Happening in Human Trials?
A Phase I trial began in late 2024 at Kyoto University Hospital (and associated centers like Kitano Hospital). This first stage is a safety study, not yet designed to prove that the drug regrows teeth in humans. ďż˝
Futura
Key points about the trial:
About 30 adult men missing at least one tooth were enrolled. ďż˝
Futura
Participants receive a single intravenous dose of TRG‑035. �
Teeth Regrowth Clinic
The main goal is to check for safety and side effects, not regrowth success. ďż˝
Teeth Regrowth Clinic
Results are expected throughout 2026, with detailed reports pending. ďż˝
Teeth Regrowth Clinic
So far, no serious safety issues have been reported in early adult dosing. ďż˝
Teeth Regrowth Clinic
đź‘¶ Next in Line: Children With Congenital Tooth Loss
If the safety data is positive, researchers plan a Phase II study targeting young children (typically ages 2–7) who were born missing multiple teeth — a condition known as congenital tooth agenesis. These children often still have the dormant tooth tissue needed for regrowth, making them better candidates. �
Futura
📆 Realistic Timeline and Expectations
If all goes well in clinical trials:
TRG‑035 could be approved for select use by around 2030. �
Futura
Initial use would likely be for children born without teeth or with severe tooth agenesis. ďż˝
Futura
Broader use in adults who lost teeth due to decay or injury may come later — and may take many more years of study. �
Teeth Regrowth Clinic
💡 What This Does and Doesn’t Mean
Here’s what TRG‑035 might do: ✔ Stimulate the body to produce biologically natural teeth
âś” Provide a living replacement rather than artificial implants
âś” Over time reduce dependence on dentures, bridges, and implants
Here’s what it does not do yet: ❌ Not available today
❌ Has not yet been proven to regrow human teeth
❌ Won’t automatically regrow a missing tooth in every adult patient
❌ Does not repair existing damaged teeth or enamel at this stage �
Futura
🔎 Expert Views and Challenges
Scientists see this research as groundbreaking, but they emphasize caution:
Some experts stress that alignment and shape control of new teeth will still require orthodontic work later. ďż˝
Futura
Others note that if the surrounding jaw bone has atrophied (as happens when a tooth is long missing), the site may not be capable of growing a new tooth without additional dental procedures first. ďż˝
Teeth Regrowth Clinic
🦷 Current Dental Care Isn’t Going Away Yet
Right now, dental implants, bridges, and dentures remain the standard of care for missing teeth, backed by decades of clinical evidence. TRG‑035 represents a potential future alternative, but it’s still in the research phase. �
Dental News
đź§ Summary
Japanese scientists are testing TRG‑035, an experimental drug that could one day activate dormant tooth buds to regrow natural teeth by blocking a protein that stops tooth formation. While animal tests have been promising, human trials are currently only assessing safety. Broad clinical use — especially for adults — could still be several years away, possibly by around 2030 or later if trials succeed. �
Futura